Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/40268
Conference/Presentation Title: | A retrospective review of fmc practice guidelines for post percutaneous coronary intervention care in metropolitan vs non-metropolitan patients. | Authors: | Sinhal A.;Lehman S.;Vaile J.;Chew D.;Jones D.;Alhammad N.;Horsfall M.;Gunton J.;Hartshorne T.;O'Shea C. | Institution: | (Jones, Alhammad, Gunton, O'Shea, Lehman, Sinhal, Vaile, Chew) School of Medicine, Flinders University of South Australia, Department of Cardio, Australia (Horsfall) South Australian Health and Medical Research Institute, Adelaide, Australia (Hartshorne) Department of Cardiology, Monash Medical Centre, Australia | Presentation/Conference Date: | 19-Oct-2016 | Copyright year: | 2016 | Publisher: | Elsevier Ltd | Publication information: | Heart Lung and Circulation. Conference: 64th Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting 2016. Adelaide, SA Australia. 25 (Supplement 2) (pp S28), 2016. Date of Publication: August 2016. | Abstract: | Stent thrombosis is a rare early complication of percutaneous coronary intervention (PCI) best managed by repeat angiography. Subsequently, our department has enforced a policy of retaining patients near a major centre for 5 days post PCI, including our rural patients. The purpose of this audit was to clarify the risk for country patients returning home within 5 days. Between January 2005 and June 2015 electronic databases identified all patients residing in SA who underwent PCI at Flinders Medical Centre (FMC), and separated them into Metro and Country designations. Demographics and comorbidities were compared, and outcomes of death, major adverse cardiac events (MACE) and MACE/Revascularisation (MACE/R) were noted within five and 30 days. In total, 3,911 patients were included (mean age: 63 years, female: 25.2%). Country patients (n= 1,412, 36.10%) were significantly less likely to have previous comorbidities, including previousACS(30.7% v 23.6%, p<0.01) and were less likely to haveMACE,both within 5 (1.5% v 0.8%, p=0.045) and 30 days (3.6% v 2.0%, p=0.004), and MACE/R within 30 days (7.0% v 4.5%, p=0.001). There was no significant difference in the rates of death within 5 or 30 days, or MACE/R within five days. Mortality by five days was low for both country and metropolitan patients (0.8% and 1.3% respectively) and did not differ significantly between groups (p=0.149). Country patients can be discharged home prior to 5 days if accepting of a <1% risk of early death within this time frame. | Conference Start Date: | 2016-08-04 | Conference End Date: | 2016-08-07 | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.hlc.2016.06.062 | ISSN: | 1444-2892 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/40268 | Type: | Conference Abstract | Type of Clinical Study or Trial: | Observational study (cohort, case-control, cross sectional or survey) |
Appears in Collections: | Conferences |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.